Mortality of Patients from COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Intra-tracheal surfactant in COVID-19 patients who are under mechanical ventilation, which includes the administration of a standard dose of surfactant inside the a
except for the intrathecal administration of surfactant. An equivalent volume of normal saline is used as placebo.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: if the patient is intubated and under mechanical ventilation with SpO2<85% If the patient has confirmed COVID-19
Exclusion criteria
Exclusion criteria: Coexisting underlying pulmonary disease except for COVID-19 Underlying congenital hear disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for mechanical ventilation. Timepoint: throughout the study, the time that patient has stayed under mechanical ventilation. Method of measurement: clinical records. | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU mortality rate. Timepoint: throughout the study in the ICU ward. Method of measurement: clinical records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Dabbagh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed